CDK4 and neoplasm: Mesenchymal-like cells with an inducible shRNA targeting CDK4 showed a greater reduction in tumor cell growth (Supplemental Figure 1, D and E), with suppression of phosphorylated RB (Figure 1D) compared with epithelial-like 393P cells.